Melanoma incidence continues to increase, yet mortality stabilizingNovember 7, 2019MelanomaOncologyDermatologyWomen's Health
Levothyroxine dose for checkpoint inhibitor toxicity may be too highNovember 4, 2019MelanomaLung CancerOncology
Prior antibiotic use lowers checkpoint inhibitor response and survivalSeptember 12, 2019Immuno-oncologyLung CancerMelanomaOncology
Another study supports safety of 2-cm margins for thick melanomasJuly 11, 2019MelanomaHematologic Malignancies
Diet appears to play an important role in response to anti-PD-1 cancer immunotherapyMarch 1, 2019Immuno-oncologyMelanoma
Poor-prognosis cancers linked to highest suicide risk in first yearJanuary 7, 2019OncologyBreast CancerGenitourinary CancerLung CancerMelanomaMental HealthPulmonology
Checkpoint inhibitor doubles 3-year survival rate of BRAF wild-type advanced melanomaOctober 25, 2018Immuno-oncologyMelanoma
Checkpoint inhibitor seems safe and effective for patients with HIVOctober 23, 2018Immuno-oncologyMelanomaLung CancerHIV
Nivolumab plus ipilimumab effective in melanoma brain metastasesAugust 27, 2018MelanomaImmuno-oncology
Using Dermoscopy to Identify Melanoma and Improve Diagnostic Discrimination (FULL)May 18, 2018MelanomaOncology
